Literature DB >> 23133800

PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5).

Dan Li1, Hong Shan, Peter Conti, Zibo Li.   

Abstract

Metabotropic glutamate receptors (mGluRs) belong to a family of G-protein coupled receptors involved in the modulation of fast excitatory transmission. In particular, the subtype-5 receptor (mGluR5) was found to be an attractive target for the treatment and diagnosis of variety of psychiatric and neurological disease including anxiety, depression, epilepsy, drug addiction, and Parkinson's disease. Positron emission tomography (PET) is a highly sensitive imaging technique that holds great potential for the diagnosis of a brain disorder. In the study published in the American Journal of Nuclear Medicine and Molecular Imaging, a (18)F labelled PET probe was developed targeting mGluR5. This paper represents the efforts and challenges on the design and development of novel PET tracers for mGluR5 imaging.

Entities:  

Keywords:  11C; 18F; mGluR5; molecular imaging; positron emission tomography (PET)

Year:  2011        PMID: 23133800      PMCID: PMC3478119     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  35 in total

Review 1.  The biochemistry of drug metabolism--an introduction: Part 2. Redox reactions and their enzymes.

Authors:  Bernard Testa; Stefanie D Krämer
Journal:  Chem Biodivers       Date:  2007-03       Impact factor: 2.408

2.  Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG-63 osteoblast-like osteosarcoma cells.

Authors:  N Kalariti; P Lembessis; E Papageorgiou; N Pissimissis; M Koutsilieris
Journal:  J Musculoskelet Neuronal Interact       Date:  2007 Apr-Jun       Impact factor: 2.041

3.  Reduced stress-induced hyperthermia in mGluR5 knockout mice.

Authors:  J Brodkin; M Bradbury; C Busse; N Warren; L J Bristow; M A Varney
Journal:  Eur J Neurosci       Date:  2002-12       Impact factor: 3.386

4.  Clinical significance of metabotropic glutamate receptor 5 expression in oral squamous cell carcinoma.

Authors:  So-Yeon Park; Seoung-Ae Lee; In-Hee Han; Byong-Chul Yoo; Seung-Hoon Lee; Jo-Yong Park; In-Ho Cha; Jin Kim; Sung-Weon Choi
Journal:  Oncol Rep       Date:  2007-01       Impact factor: 3.906

Review 5.  Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis.

Authors:  Gurpreet K Dhami; Stephen S G Ferguson
Journal:  Pharmacol Ther       Date:  2006-03-06       Impact factor: 12.310

6.  Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.

Authors:  Simon M Ametamey; Lea J Kessler; Michael Honer; Matthias T Wyss; Alfred Buck; Samuel Hintermann; Yves P Auberson; Fabrizio Gasparini; Pius A Schubiger
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

7.  Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.

Authors:  Simon M Ametamey; Valerie Treyer; Johannes Streffer; Matthias T Wyss; Mark Schmidt; Milen Blagoev; Samuel Hintermann; Yves Auberson; Fabrizio Gasparini; Uta C Fischer; Alfred Buck
Journal:  J Nucl Med       Date:  2007-02       Impact factor: 10.057

8.  Up-regulation of hippocampal metabotropic glutamate receptor 5 in temporal lobe epilepsy patients.

Authors:  Robbert G E Notenboom; David R Hampson; Gerard H Jansen; Peter C van Rijen; Cees W M van Veelen; Onno van Nieuwenhuizen; Pierre N E de Graan
Journal:  Brain       Date:  2005-11-25       Impact factor: 13.501

9.  Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.

Authors:  Daniela Pellegrino; Francesca Cicchetti; Xukui Wang; Aijun Zhu; Mexiang Yu; Martine Saint-Pierre; Anna-Liisa Brownell
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

Review 10.  Glutamate receptors and Parkinson's disease: opportunities for intervention.

Authors:  Michael J Marino; Ornella Valenti; P Jeffrey Conn
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more
  3 in total

Review 1.  Quantum dot-based nanoprobes for in vivo targeted imaging.

Authors:  Y Zhu; H Hong; Z P Xu; Z Li; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 2.  Metabotropic glutamate receptor 5 as a potential target for smoking cessation.

Authors:  Cristiano Chiamulera; Claudio Marcello Marzo; David J K Balfour
Journal:  Psychopharmacology (Berl)       Date:  2016-11-16       Impact factor: 4.530

3.  Synthesis and Preliminary Studies of a Novel Negative Allosteric Modulator, 7-((2,5-Dioxopyrrolidin-1-yl)methyl)-4-(2-fluoro-4-[11C]methoxyphenyl) quinoline-2-carboxamide, for Imaging of Metabotropic Glutamate Receptor 2.

Authors:  Xiaofei Zhang; Katsushi Kumata; Tomoteru Yamasaki; Ran Cheng; Akiko Hatori; Longle Ma; Yiding Zhang; Lin Xie; Lu Wang; Hye Jin Kang; Douglas J Sheffler; Nicholas D P Cosford; Ming-Rong Zhang; Steven H Liang
Journal:  ACS Chem Neurosci       Date:  2017-06-13       Impact factor: 4.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.